Friday, May 1, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Trends

The WHO Pandemic Treaty Debate: Global Unity or Sovereign Resistance?

As negotiations intensify, the proposed treaty reveals deep divides over health governance, sovereignty, and global crisis management.

Kumar Ramalingam by Kumar Ramalingam
April 30, 2025
in Politics & Law
0

As memories of COVID-19’s global chaos linger, the international community is grappling with an ambitious yet polarizing idea: a legally binding World Health Organization (WHO) Pandemic Treaty. Intended to bolster global preparedness and ensure faster, more coordinated responses to future pandemics, the treaty has become a lightning rod for debates about sovereignty, equity, and trust in multilateral institutions.

Negotiations, formally launched in December 2021, are approaching a critical juncture. Member states are now wrangling over the treaty’s scope, enforcement mechanisms, and the delicate balance between national authority and collective global action. According to official WHO documents, the treaty aims to strengthen early warning systems, promote equitable access to vaccines and treatments, and enhance the transparency of pathogen sharing (WHO, 2024). Yet the details—and the politics—have proven to be formidable obstacles.

A bloc of countries led by the United States, Brazil, and India has expressed reservations about any provisions that could potentially infringe on national decision-making during a health emergency. Critics argue that ceding authority to a supranational body, even in a narrowly defined crisis context, could erode sovereign rights. As one senior U.S. State Department official anonymously told The Washington Post, “While global cooperation is essential, we cannot sign away our constitutional autonomy” (The Washington Post, 2025).

Conversely, advocates, including the European Union and a coalition of African nations, contend that global health threats demand global solutions. Citing the fragmented and often nationalistic responses during the COVID-19 pandemic, proponents warn that without binding commitments, the world risks repeating past failures. An editorial in The Lancet emphasized that “global public goods like vaccines cannot be left to the whims of nationalism and market forces” (The Lancet, 2025).

Underlying these disagreements are thorny issues of equity and historical distrust. Many low- and middle-income countries, still bitter over vaccine hoarding during COVID-19, are demanding firm guarantees for technology transfer, financing, and equitable resource distribution in future crises. According to a recent policy brief by the Centre for Global Development, without concrete mechanisms for accountability, promises of “solidarity” risk being little more than rhetorical gestures (CGD, 2025).

Adding further complexity, conspiracy theories have flourished online, falsely suggesting that the treaty would grant the WHO unchecked power to impose lockdowns, mandate vaccinations, or override national governments. WHO Director-General Dr. Tedros Adhanom Ghebreyesus has repeatedly stressed that the treaty would “respect national sovereignty” while enhancing cooperation, but disinformation has muddied public understanding (WHO, 2025).

The stakes are high. With the final draft slated for consideration at the World Health Assembly in mid-2025, failure to reach consensus could signal a retreat from multilateralism at precisely the moment when global challenges—from pandemics to climate change—demand deeper collaboration.

As political scientist Dr. Sara Bennett of Johns Hopkins University observed in a recent commentary, “The pandemic treaty negotiations are a bellwether for the future of global governance. Whether we can build frameworks for shared risk and shared responsibility—or whether nationalism will prevail—remains an open and urgent question” (Global Public Health Review, 2025).

In an increasingly interconnected world, the choice between fragmentation and cooperation is not merely academic. It is a defining test of whether humanity can transcend political divisions to confront existential threats together.

ShareTweet
Kumar Ramalingam

Kumar Ramalingam

Kumar Ramalingam is a writer focused on the intersection of science, health, and policy, translating complex issues into accessible insights.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • A doctor tapping a tablet near a window in their office during the daytime. The doctor smiles at the tablet.

    The Importance of Access Control in the Workplace

    0 shares
    Share 0 Tweet 0
  • Drug Pricing Transparency in an Era of Political Polarization: What MedPricer’s Data Reveals About a Contested Policy Landscape

    0 shares
    Share 0 Tweet 0
  • Employer-Sponsored Insurance Is Breaking Down. Price Data Tells You Where It’s Happening First.

    0 shares
    Share 0 Tweet 0
  • State Regulators and the Federal Data Gap: How MedPricer Fills What CMS Leaves Incomplete

    0 shares
    Share 0 Tweet 0
  • The Price Database That Reporters Keep Ignoring

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy